Cargando…

SIOP PNET5 MB Trial: History and Concept of a Molecularly Stratified Clinical Trial of Risk-Adapted Therapies for Standard-Risk Medulloblastoma

SIMPLE SUMMARY: The European trial SIOP PNET5 MB was initiated in 2014 and will remain open to recruitment until 2022. It is the first European trial using clinical, histological, and molecular parameters to stratify treatments for childhood medulloblastoma, based on disease risk. In the standard-ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mynarek, Martin, Milde, Till, Padovani, Laetitia, Janssens, Geert O., Kwiecien, Robert, Mosseri, Veronique, Clifford, Steven C., Doz, François, Rutkowski, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657236/ https://www.ncbi.nlm.nih.gov/pubmed/34885186 http://dx.doi.org/10.3390/cancers13236077

Ejemplares similares

QOL-17. BIOLOGICAL CORRELATES OF QUALITY OF SURVIVAL AND NEUROCOGNITIVE OUTCOMES IN MEDULLOBLASTOMA; A META-ANALYSIS OF THE SIOP-UKCCSG-PNET3 AND HIT-SIOP-PNET4 TRIALS
por: Chevignard, Mathilde, et al.
Publicado: (2020)

Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial
por: Bailey, Simon, et al.
Publicado: (2022)

Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial
por: Clifford, Steven C., et al.
Publicado: (2015)

Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study
por: Sabel, Magnus, et al.
Publicado: (2016)

Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial
por: Goschzik, Tobias, et al.
Publicado: (2018)

Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma: First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial
por: Dietzsch, Stefan, et al.
Publicado: (2020)

MEDB-40. RUNNING FOR INCLUSION IN SIOPE PNET5 MB
por: Massimino, Maura, et al.
Publicado: (2022)

Treatment Outcomes of Childhood Medulloblastoma with the SIOP/UKCCSG PNET-3 Protocol
por: Kartal, İbrahim, et al.
Publicado: (2023)

Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma—an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial
por: Dietzsch, Stefan, et al.
Publicado: (2021)

QOL-24. DIFFERENTIAL IMPACT OF TUMOR LOCATION, LOCAL AND CRANIOSPINAL IRRADIATION ON NEUROPSYCHOLOGICAL LONG-TERM OUTCOME IN CHILDREN WITH MEDULLOBLASTOMA, EPENDYMOMA AND SUPRATENTORIAL PNET: A LONGITUDINAL MULTICENTER OUTCOME ASSESSMENT OF CHILDREN FROM THE HIT-2000 AND HIT-REZ TRIALS
por: Ottensmeier, Holger, et al.
Publicado: (2020)

Increased p53 immunopositivity in anaplastic medulloblastoma and supratentorial PNET is not caused by JC virus
por: Eberhart, Charles G, et al.
Publicado: (2005)

Development of zebrafish medulloblastoma-like PNET model by TALEN-mediated somatic gene inactivation
por: Shim, Jaegal, et al.
Publicado: (2017)

Taste and smell function in long-term survivors after childhood medulloblastoma/CNS-PNET
por: Tanem, Kristine Eidal, et al.
Publicado: (2022)

PATH-07. QUALITY ASSURANCE IN CEREBROSPINAL FLUID CYTOLOGY ASSESSMENT FOR MEDULLOBLASTOMA STAGING LEADS TO POTENTIAL IMPROVED RISK-GROUP ASSESSMENT IN THE PROSPECTIVE MULTICENTER HIT-2000 TRIAL
por: Hagel, Christian, et al.
Publicado: (2020)

MEDB-61. Genetic alterations ofTP53 andOTX2 indicate increased risk of relapse in WNT medulloblastomas
por: Goschzik, Tobias, et al.
Publicado: (2022)

Development of mediastinal lymphoma after radiotherapy for concurrent medulloblastoma and PNET in a patient with Gorlin syndrome
por: Jiang, Tao, et al.
Publicado: (2016)

Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG)
por: Guerrini-Rousseau, L., et al.
Publicado: (2021)

The current status of treatment of Wilms’ tumor as per the SIOP trials
por: Godzinski, Jan
Publicado: (2015)

Mitochondrial DNA mutations in Medulloblastoma
por: Funke, Viktoria L. E., et al.
Publicado: (2023)

A rapid review of evidence and recommendations from the SIOPE radiation oncology working group to help mitigate for reduced paediatric radiotherapy capacity during the COVID-19 pandemic or other crises()
por: Janssens, Geert O., et al.
Publicado: (2020)

Care of adolescents and young adults with cancer in Asia: results of an ESMO/SIOPE/SIOP Asia survey
por: Li, Chi Kong, et al.
Publicado: (2019)

Local and Systemic Therapy of Recurrent Medulloblastomas in Children and Adolescents: Results of the P-HIT-REZ 2005 Study
por: Gaab, Christine, et al.
Publicado: (2022)

Group-specific cellular metabolism in Medulloblastoma
por: Funke, Viktoria L. E., et al.
Publicado: (2023)

Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas
por: Goschzik, Tobias, et al.
Publicado: (2022)

The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma
por: Ghasemi, David R., et al.
Publicado: (2022)

Congenital sacrococcygeal PNET and chemotherapy
por: Hawkes, Colin Patrick, et al.
Publicado: (2012)

MBCL-06. RISK STRATIFICATION IMPROVEMENT OF THE HIT2000 AND I-HIT-MED COHORTS USING MOLECULAR SUBTYPES I-VIII OF GROUP 3/4 MEDULLOBLASTOMAS
por: Mynarek, Martin, et al.
Publicado: (2020)

Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group
por: De Bernardi, B, et al.
Publicado: (2008)

MEDB-37. Chemotherapy response prediction by molecular risk factors in metastatic childhood medulloblastoma
por: Obrecht, Denise, et al.
Publicado: (2022)

Risk Factors of Lymph Node Metastasis in Patients with Pancreatic Neuroendocrine Tumors (PNETs)
por: Wang, Zhe, et al.
Publicado: (2020)

Evaluation of the Perioperative and Postoperative Course of Surgery for Pineal Germinoma in the SIOP CNS GCT 96 Trial
por: Shabo, Ehab, et al.
Publicado: (2022)

PNET of kidney: Report of four cases
por: Mandal, Palash Kumar, et al.
Publicado: (2012)

PNET périphérique à localisation mésentérique
por: Kamaoui, Imane, et al.
Publicado: (2014)

Management of Wilms' tumor: NWTS vs SIOP
por: Bhatnagar, Sushmita
Publicado: (2009)

QOL-13. NEUROCOGNITIVE OUTCOMES ACCORDING TO RISK-ADAPTED TREATMENT REGIMENS FOR CHILDREN OLDER THAN 4 WITH MEDULLOBLASTOMA AND POSTERIOR FOSSA EPENDYMOMA – RESULTS OF THE HIT2000 TRIAL
por: Mynarek, Martin, et al.
Publicado: (2020)

The need for consensus on delineation and dose constraints of dentofacial structures in paediatric radiotherapy: Outcomes of a SIOP Europe survey
por: Davey, Angela, et al.
Publicado: (2023)

MEDB-16. Persistent radiological lesions at the end of primary therapy in childhood medulloblastoma: residual lesion or active residual tumor?
por: Schömig, Lena, et al.
Publicado: (2022)

The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG survey
por: Seravalli, Enrica, et al.
Publicado: (2021)

MEDB-51. Impact of residual tumor on outcomes in children and adolescents with medulloblastoma in the German HIT-cohort
por: Wolgast, Stella, et al.
Publicado: (2022)

Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma – A Report From the HIT 2000 Trial
por: Dietzsch, Stefan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tpdks1on3gqsr6ekm3didb5c3i